A Comparative Effectiveness Trial of Extended-Release Naltrexone versus Extended-Release Buprenorphine with Individuals Leaving Jail
Principal Investigator(contact): Michael S. Gordon, D.P.A.
Principal Investigator: Shannon Gwin Mitchell, Ph.D.
Co-Investigator: Thomas Blue, Ph.D.
Co-Investigator: Frank Vocci, Ph.D.
Co-Investigator: Sean Murphy, Ph.D.
Co-Investigator: Marc Fishman, M.D.
Project Director: Kathy Couvillion
Funded By: National Institute on Drug Abuse
Grant #: 5UG1DA050077
Total Project Period: 7/19 – 4/24
[Abstract]

A Comparative Effectiveness Trial of Sublingual Versus Extended-release Buprenorphine with Individuals Leaving a Carceral Setting
Principal Investigator(contact): Michael S. Gordon, D.P.A.
Principal Investigator: Thomas Blue, Ph.D.
Co-Investigator: Frank Vocci, Ph.D.
Co-Investigator: Kathy Couvillion
Funded By: National Institute on Drug Abuse
Grant #: 1R01DA058674
Total Project Period: 9/23 – 6/28
[Abstract]

A Comparison of Sublingual and Extended-release Buprenorphine for Individuals Leaving Jail
Principal Investigator(contact): Michael S. Gordon, D.P.A.
Principal Investigator: Shannon Gwin Mitchell, Ph.D.
Funded By: National Institute on Drug Abuse
Grant #: 3UG1DA050077
Total Project Period: 9/22 - 4/24
[Abstract]

Buprenorphine for Probationers and Parolees: Bridging the Gap into Treatment
Principal Investigator: Michael S. Gordon, D.P.A.
Co-Investigator: Frank J. Vocci, Ph.D.
Co-Investigator: Marc J. Fishman, M.D.
Co-Investigator: Faye S. Taxman, Ph.D.
Project Director: Kathryn Couvillion
Funded By: National Institute on Drug Abuse
Grant #: 1R01DA043476
Total Project Period: 7/18 - 4/24
[Abstract]

Continuing Care App for Justice-Involved Individuals with Substance Use Disorders
Principal Investigator(contact): Michael S. Gordon, D.P.A.
Principal Investigator: Steven B. Carswell, Ph.D.
Co-Investigator: Thomas Blue, Ph.D.
Co-Investigator: Frank J. Vocci, Ph.D.
Co-Investigator: Faye S. Taxman, Ph.D.
Co-Investigator: Jan Gryczynski, Ph.D.
Co-Investigator: Karen Alexander, Ph.D.
Co-Investigator: Mishka Terplan, M.D., M.P.H., FACOG, DFASAM
Funded By: National Institute on Drug Abuse
Grant #: 1UG3DA058305
Total Project Period: 6/23 – 5/25
[Abstract]

Development of a Novel Drug for Treating Opioid Use Disorder
Principal Investigator(contact): Nikej Shah, M.D.(Nirsum Laboratories, Inc.)
Principal Investigator: Frank J. Vocci, Ph.D.
Funded By: National Institute on Drug Abuse via Nirsum Laboratories, Inc.
Grant #: 1UG3DA048234, Subaward NIRSUM0002
Total Project Period: 9/22 – 8/25
[Abstract]

Healthy Brain and Child Development National Consortium
Principal Investigator(contact): Brittany Rollins Howell, Ph.D.(Virginia Polytechnic Institute & State University)
Principal Investigator: Martha Ann Bell, Ph.D. and Kathryn W. Hosig, R.D., M.P.H., Ph.D. (Virginia Polytechnic Institute & State University)
Co-Investigator: Mishka Terplan, M.D., M.P.H., FACOG, DFASAM
Funded By: National Institute on Drug Abuse via Virginia Polytechnic Institute & State University
Grant #: 5U01DA055357, Subaward 412797-19F49
Total Project Period: 7/22 – 6/26
[Abstract]

Identifying Suspected Drug Overdose Deaths in Near Real-Time Using Data Collected by Death Investigators
Principal Investigator: Karli Hochstatter, Ph.D., M.P.H.
Co-Investigator: Nabila El-Bassel, Ph.D. and Smaranda Muresan, Ph.D. (Columbia University)
Co-Investigator: Jan Gryczynski, Ph.D.
Funded By: National Institute on Drug Abuse
Grant #: 1R01DA057685-01
Total Project Period: 9/22 – 9/25
[Abstract]

Implementing a Patient Navigation Intervention Across a Health System to Address Treatment Entry Inequities
Principal Investigator(contact): Karen Alexander, Ph.D.
Principal Investigator: Jan Gryczynski, Ph.D.
Co-Investigator: Shannon Gwin Mitchell, Ph.D.
Co-Investigator: Courtney Nordeck, Ph.D.
Co-Investigator: Mishka Terplan, M.D., M.P.H., FACOG, DFASAM
Funded By: National Institute on Drug Abuse
Grant #: 1R61DA059033-01A1
Total Project Period: 9/23 – 8/25
[Abstract]

Intervention to Reduce Internalized Stigma (IRIS) Among People Living with HIV who Use Substances
Principal Investigator(contact): Jesse Fletcher, Ph.D.
Principal Investigator: Alicia Lucksted, Ph.D. (University of Maryland School of Medicine)
Co-Investigator: Shannon Gwin Mitchell, Ph.D.
Funded By: National Institute on Drug Abuse
Grant #: 5R34DA055532-02
Total Project Period: 9/22 – 7/25
[Abstract]

Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults
Principal Investigator(contact): Joshua D. Lee, M.D., M.S(New York University School of Medicine)
Principal Investigator: Jan Gryczynski, Ph.D.
Co-Investigator: Laura B. Monico, Ph.D.
Project Manager: Katherine H. Melton, M.A.
Funded By: National Institute on Drug Abuse via New York University School of Medicine
Grant #: 1U01DA047982, Subaward 18-A0-00-1001703
Total Project Period: 8/19 – 4/24
[Abstract]

Long-acting Injectable Antiretroviral Treatment to Improve HIV Treatment among Justice-involved Persons Being Released to the Community
Principal Investigator(contact): Curt G. Beckwith, M.D.(The Miriam Hospital)
Principal Investigator: Michael S. Gordon, D.P.A.
Co-Investigator: Thomas R. Blue, Ph.D.
Funded By: National Institute on Drug Abuse via The Miriam Hospital
Grant #: 5R34DA057165, Subaward 7147302MSG
Total Project Period: 9/22 – 7/25
[Abstract]

Long-acting Naltrexone for Pre-release Prisoners: A Randomized Trial of Mobile Treatment
Principal Investigator: Michael S. Gordon, D.P.A.
Co-Principal Investigator: Frank J. Vocci, Ph.D.
Co-Investigator: Terrence T. Fitzgerald, M.D. (Glenwood Life Counseling Center)
Project Director: Kathryn Couvillion
Funded By: National Institute on Drug Abuse
Grant #: 1R01DA040636
Total Project Period: 8/16 - 4/24
[Abstract]

Long-acting Naltrexone for Pre-release Prisoners: A Randomized Trial of Mobile Treatment
Principal Investigator(contact): Michael S. Gordon, D.P.A.
Co-Investigator: Thomas Blue, Ph.D.
Co-Investigator: Frank J. Vocci, Ph.D.
Funded By: National Institute on Drug Abuse
Grant #: 3UG1DA050077
Total Project Period: 5/23 - 4/24
[Abstract]

Opioid Use Disorder Treatment Linkage at STD Clinics using Buprenorphine (OUTLAST-B)
Principal Investigator: Jan Gryczynski, Ph.D.
Co-Investigator: Robert P. Schwartz, M.D.
Co-Investigator: Shannon Gwin Mitchell, Ph.D.
Co-Investigator: Kathleen Page, M.D.
Funded By: National Institute on Drug Abuse
Grant #: 1R01DA045724
Total Project Period: 4/19 – 1/25
[Abstract]

Scope and Impact of Methadone Take-home and Telehealth Practice Changes During the COVID-19 Pandemic
Principal Investigator: Jan Gryczynski, Ph.D.
Co-Investigator: Robert P. Schwartz, M.D.
Co-Investigator: Mishka Terplan, M.D., M.P.H., FACOG, DFASAM
Co-Investigator: Karli Hochstatter, Ph.D.
Funded By: National Institute on Drug Abuse
Grant #: 5R01DA057052-02
Total Project Period: 9/22 – 6/26
[Abstract]

The Youth Opioid Recovery Support (YORS) Intervention: An Assertive Community Treatment Model for Improving Medication Adherence in Young Adults with Opioid Use Disorder
Principal Investigator: Marc J. Fishman, M.D. (Maryland Treatment Centers, Inc.)
Co-Investigator: Shannon Gwin Mitchell, Ph.D.
Co-Investigator: Mishka Terplan, M.D., M.P.H., FACOG, DFASAM
Funded By: National Institute on Drug Abuse via Maryland Treatment Centers, Inc.
Grant #: 4R33DA056230-02, Subaward 78R33FRI1
Total Project Period: 9/21-8/24
[Abstract]

Treating Polysubstance Use in Methadone Maintenance: Application of Novel Digital Technology
Principal Investigator: Shannon Gwin Mitchell, Ph.D.
Co-Investigator: Jesse Fletcher, Ph.D.
Co-Investigator: Jan Gryczynski, Ph.D.
Co-Investigator: Karen Alexander, Ph.D.
Funded By: National Institute on Drug Abuse
Grant #: 1R01DA057608-01
Total Project Period: 9/22 – 9/25
[Abstract]